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a b s t r a c t
Objectives: To verify the value of conventional cytology for the diagnosis of macroscopic le-
sions of the anal canal and to describe the limitations of the samples.
Method: We evaluated 395 conventional cytology samples obtained by brushing the anal 
canal of patients (predominantly male, HIV-positive) and compared them to the presence 
of macroscopic lesions of the anal canal observed under anorectal examination.
Results: Of the total, 91.6% of samples were classifi ed as adequate. Cellular elements repre-
sentative of the anal transformation zone were observed in 63.5% of samples. Sensitivity in 
the presence or absence of cellularity was 80% and 31%, respectively.
Conclusion: The study demonstrates the feasibility of using conventional anal cytology in 
outpatients.
© 2014 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. 




Prevenção de neoplasia anal
Citologia convencional
r e s u m o
Objetivo: verifi car o valor da citologia convencional no diagnóstico de lesões macroscópicas 
do canal anal e descrever as limitações das amostras obtidas.
Método: avaliamos 395 exames citológicos convencionais obtidos por escovado do canal 
anal de pacientes predominantemente do sexo masculino, soropositivos para HIV, e com-
paramos com a presença de lesões macroscópicas do canal anal constatadas ao exame 
proctológico. 
Resultado: o percentual de amostras adequadas foi de 91,6%, e os elementos celulares re-
presentativos da zona de transformação anal foram observados em 63,5% das amostras. 
Encontramos sensibilidade de 80% e 31% na presença ou ausência desta celularidade, res-
pectivamente.
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Conclusão: O estudo demonstra a possibilidade de utilização da citologia anal convencional 
no rastreio de lesões macroscópicas do canal anal em pacientes ambulatoriais.
© 2014 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. 
Introduction
The incidence of anal squamous cell carcinoma and its pre-
cursor lesions increased in recent decades, and it has been 
widely proven the participation of HPV (human papillomavi-
rus) types 16 and 18 in its pathogenesis.1
Although still a relatively rare cancer, its incidence has 
been rising alarmingly in younger patients, especially men 
who practice receptive anal sex with men (MSM, so-called 
by its acronym in English), independent of HIV infection, but 
with greater involvement of those infected with this virus. 
Women with a history of multicentric squamous intraepithe-
lial neoplasia, heterosexual men and women HIV-positive or 
immunosuppressed for other reasons also have contributed 
to the increased incidence of this neoplasia.2
In Brazil we do not have data on the incidence of anal can-
cer, because they are included in the colon and rectum to-
pography. In these topographies 14,180 and 15,960 new cancer 
cases in men and in women, respectively, are expected, cor-
responding to an estimated risk of 15 new cases per 100,000 
men and 16 new cases per 100,000 women.3 Regarding the 
situation of AIDS, there has been an increase in the number 
of cases of the disease in young people included in the MSM 
exposure category.4
The highly active antiretroviral therapy (HAART) seems 
not to modify the pathophysiology of HPV anal lesion in HIV-
infected patients, suggesting that a progression to serious in-
jury should occur in patients with prolonged survival.5
The similarities between cervical and anal cancers, for in-
stance, the association with HPV, the greater occurrence in 
the existing epithelial transformation zone in both topogra-
phies and the ability to diagnose early lesions susceptible to 
less aggressive treatments, led to the use of exfoliative cy-
tology as a diagnostic test for more than a decade, and this 
procedure can be performed by the conventional method or 
in liquid medium, with similar results. Still, the current inci-
dence of anal cancer is similar to that of cervical cancer be-
fore the establishment of prevention programs, bringing great 
expectations in the use of anal cytology.1,2
Several studies show that cytology has a good sensitivity 
but low specificity. A meta-analysis reported variations in sen-
sitivity between 42 and 98% and of specificity between 16 and 
96%.1 An important factor for this variation may be due to lack 
of standardization of how the cytobrush should be introduced 
into the anal canal6 and to the greater difficulty in the obtain-
ment and preparation of anal canal samples, compared with 
the cervical collection.7 The evaluation of the screening effec-
tiveness for long-term prevention of anal as well as cervical 
cancer still remains to be done,1 A contributing factor to this 
performance variation is the little experience of cytopatholo-
gists with the sampling procedure in the anal canal. Aiming at 
the improvement of this procedure, the College of American 
Pathologists (CAP) recommends the ampliation of its use.2
In this study we report the performance of this test in the 
presence of macroscopic lesions in the anal canal in outpa-
tients seen at the Hospital Federal de Ipanema/MS/Rio de 
Janeiro, using the conventional method, a technology widely 
available in our country. Should it prove appropriate, it will 
contribute for the prevention of anal canal cancer in outpa-
tient visits.
Material and method
From April 2005 to December 2011, 395 cytopathology exams 
of anal canal were compared with the clinical diagnosis of 
presence of macroscopic lesions. The information was ex-
tracted from cytologic requisitions and medical records of the 
patients examined. 
The study was approved by the Ethics Committee on Hu-
man Research of the Hospital Federal dos Servidores do Es-
tado (CEP_HFSE - 000474 protocol).
Patients whose samples were included in this trial were 
mostly men attended at our proctology outpatient clinic. The 
reasons of the visits were anal sex practice, some anal claim 
arising out of sexually transmitted disease or otherwise, pres-
ence of warts, or seropositivity for HIV. Samples of three pa-
tients from the gynaecology outpatient clinic were also includ-
ed. One of them had perianal condylomata and the other two a 
diagnosis of vulvar intraepithelial neoplasia (VIN II and VIN III). 
In most cases, the sampling was done in two slides at the 
first consultation, because no prior preparation is necessary. 
Patients who reported having receptive anal sexual relation-
ship or made  use of suppositories, creams or enema the day 
before the consultation were told to return later, observing 
the necessary precautions before collection.
As for the collection, two clean glass slides with frosted 
end, with the initials and clinical record number of the pa-
tient, and an unplugged slide rack tube containing ethyl al-
cohol up to 1 cm from the edge were arranged on a auxiliary 
table. The patient was placed in the Sims (left lateral decubi-
tus position, with legs tucked) or gynaecological position. The 
anal slit was then opened with the left hand of the operator, 
and the patient was requested to help in the case of bulky 
buttocks, to prevent contamination with external condilo-
mata, when present. With the right hand, the operator intro-
duced a cytobrush previously moistened with distilled water 
or physiological saline for 4-5 cm, in order to reach the anal 
transformation zone starting 1 cm below the pectineal line 
and extending up to 2 cm above its upper edge. Then, soft and 
slow rotation movements were preformed, pressing lightly on 
the wall of the anal canal and lower rectum, and the collec-
tion was carried out blindly.
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The cytobrush containing the collected material was then 
rotated with a uniform motion on the central part of each slide, 
resulting in thin smears arranged longitudinally that, within 10 
seconds and still wet, were totally immersed in hydrated ethyl 
alcohol for fi xation of the samples (Fig. 1).
After collection, an inspection with conventional touch and 
anoscopy was performed. In patients older than 50 years a rec-
tosigmodoscopy was also performed. Then, the samples were 
sent for the Pathology Service, along with the application form 
containing clinical data; there, the slides were stained by Papa-
nicolaou. The reports were issued by an experienced cytopa-
thologist reporting the representativeness of epithelia present 
in the sample and the diagnostics, based on cytomorphological 
criteria for diagnostic elaboration according to The Bethesda 
System for Reporting Cervical Cytology8 (Fig. 2). Considering 
that the conventional method was used, the criteria for the ad-
equacy of the sample were based on the 1991 version of The 
Bethesda System, which defi nes the sample as “paucicellular” 
when it covers less than 10% of the surface of the slide, and 
“prejudiced” when fi xation artefacts, overlapping, blood stains 
and other contaminants affect 50-75% of the sample.
Samples composed exclusively of keratinized squamous 
cells; paucicellular samples; or those with artefacts of fi xation, 
overlapping, exudate, erythrocytes and faecal material that 
prevented the diagnosis were judged unsatisfactory.
Data were stored in spreadsheets and analyzed using 
SPSS v. 21.
Results 
The sample consists of 395 cytological exams of patients pre-
dominantly male, and, among these, of HIV-seropositive ones 
(59.7%). Most patients (61.2%) presented lesions at the time of 
collection. The injury to the anal canal, visualized by conven-
tional anoscopy, was present in 31.7% of men and in 22.5% 
women (Table 1). 
At the moment of the collection, the clinical inspection of 
the perianal region and a conventional anoscopy showed pre-
dominance of macroscopic lesions in HIV-positive patients 
(62.5%) (data not shown).
Most of the samples were judged satisfactory by evalua-
tion according to the criteria defi ned by Bethesda (Table 2). 
The most frequent cause of limitation of samples was pauci-
Table 1 – Characteristics of patients from whom the 
specimens for cytopathological exam of anal canal (HFI/
MS, 2005-2011) were obtained (cytobrushing).
Characteristics Male Female Total
Mean age in years (range) 36.8 (16-84) 41.9 (21-80) 37.9 (16-84)
HIV situation 
HIV+ 188 (59.7%) 15 (18.7%) 203
HIV - 64 (20.3%) 29 (36.2%) 93
HIV unknown 63 (20%) 36 (45%) 99
Presence of macroscopic 
lesion
Perianal 102 (32.3%) 22 (27.5%) 124
Anal canal 45 (14.3%) 15 (18.7%) 60
Both 55 (17.6%) 3 (3.8%) 58
Absence of perianal or 
anal canal lesion
113 (35.8%) 40 (50%) 153
Total 315 80 395
Fig. 1 – Appearance of adequate Pap smears after staining.
Fig. 2 – A, Columnar cells from the anal transformation 
zone. B, Low-grade anal intraepithelial lesion. C, High-
grade anal intraepithelial lesion. (Conventional cytology 
stained by Papanicolaou method ×400.)
Table 2 – Classifi cation of the adequacy of smears 




Satisfactory samplesa 292 (92.6%) 70 (87%) 362 (91.6%)
Unsatisfactory 
samplesb
6 (60%) 4 (40%) 10 (2.5%)
Limited samplesc 17 (73.9%) 6 (26%) 23 (5.8%)
Total 315 80 395
a Representative and preserved cellularity, composed of keratinized 
and non-keratinized squamous cells and/or transitional and/
or columnar cells. b Unrepresentative cellularity, consisting 
exclusively of keratinized squamous cells. c Limited cellularity, with 
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cellularity (43.4%) followed by exudate, bacteria and hematic 
background. The artefacts of fixation (13%) and faecal mate-
rial presence (4.3%) had low significance.
The analysis of the frequency of unsatisfactory samples 
over time demonstrates a downward trend, but the same was 
not observed with respect to the limited samples. There was 
a increase in this category in 2011, due to paucicellularity and 
exudate. The downward trend in the proportion of inadequate 
samples was statistically significant (linear regression, p = 
0.048821) (Table 3).
Representative elements of the anal transformation zone 
in 63.5% of samples were found, with no significant difference 
between genders (data not shown). 
Among the tests considered satisfactory and altered, a 
predominance of low-grade lesions was perceived, especially 
in men; but it is worth mentioning a significant percentage of 
diagnoses of major relevance (Table 4). 
The analysis of the diagnostic performance of anal cytol-
ogy for detection of macroscopic lesions of the anal canal 
showed significant increase in sensitivity when the collection 
brought representative elements of the anal transformation 
zone (Table 5).
Discussion
The prevention of anal cancer in Brazil is critical. Informa-
tion campaigns are essential to reach a population exceed-
ing 1.5 million MSM, according to a survey conducted on 
attitudes and practices in the Brazilian population in 2008 
(PCAP-BR)9 and women with a history of genital intraepithe-
lial neoplasia.10
The methodology of liquid medium is still incipient among 
us and the biased and critical view of the conventional meth-
od, which is widely available, has resulted in few services per-
forming exfoliative cytology of the anal canal. 
The use of this method in services that do not have an 
anoscope, including those providing care for HIV+ patients, 
should be encouraged to evaluate the presence of injury and 
to referral of patients with abnormal tests for centres with 
adequate equipment.11 Protocols and diagnostic algorithms 
based on cytologic changes are already suggested, in order to 
reduce the incidence of anal cancer in high-risk populations.12
The intent of this study was to evaluate the performance 
of conventional exfoliative cytology in the diagnosis of mac-
roscopic lesions in the anal canal. We also analyzed the 
procedure as a function of sample quality. The lack of in-
formation about subclinical lesions prevents a more accu-
rate analysis of this performance, but many patients remain 
continue to be followed-up, having been submitted to high-
resolution anoscopy and biopsies, both liable to assessment 
in a next step.
The reduced percentage of unsatisfactory samples in this 
study is similar to the 6% reported by Mathews WC et al.,13 
while studying 2,947 conventional smears of the anal canal. 
We believe that the training given to proctologists, coupled 
with the fact that the same physician collected most samples 
(78%), has contributed to our results, being an essential step 
in implementing the use of this practice in a health care facil-
ity. On the other hand, Sherman et al.,14 after months of train-
ing, considered most of conventional samples unsatisfactory, 
attributing the failure to the fact that the professionals in-
volved in the collection, both medical and nonmedical, had 
no prior experience in collecting this type of sample.
Table 3 – Evolution of the percentage of inadequate samples in smears obtained from anal cytobrushing over the years 
of study (HFI/MS, 2005-2011).
2005 2006 2007 2008 2009 2010 2011 Total
Number of 
exams 
14 22 68 57 52 81 101 395
Unsatisfactory 
samples
3 1 5 0 0 1 0 10
Limited 
samples




3 2 14 4 3 2 5 33
% 21.4% 9.0% 20.5% 14.0% 5.7% 2.46% 4.95%
* Result of the sum of unsatisfactory and limited samples.
Table 4 – Cytopathological diagnoses of smears considered as satisfactory, obtained by anal cytobrushing (HFI/MS, 2005-
2011).
Cytopathological diagnosis Male Female Total
Negative 166 (56.8%) 51 (72.8%) 217 (59.9%)
Atypical squamous cells, possibly non neoplastic. ASC-US 37 (12.7%) 7 (10%) 44 (12.1%)
Atypical squamous cells, not to discard high-grade lesionASC-H 4 (0.13%) 0 (0%) 04 (1.1%)
Low-grade anal intraepithelial lesion 69 (23.6%) 8 (11.4%) 77 (21.3%)
High-grade anal intraepithelial lesion 15 (5.1) 4 (5.7%) 19 (5.2%)
Carcinoma 1 (0.34) 0 (0%) 01 (0.3%)
TOTAL 292 70 362
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Our experience with anal canal cytology began in 2005 
with the examination of smears obtained from patients in-
cluded in this study, when several studies had already de-
scribed the differences between cytological samples of cer-
vical and anal canal.7,14-16 One of our concerns was to meet 
the criteria contained in The ABCs of anal-rectal cytology 
CAP May 2004,17 limiting the inconclusive diagnoses of atyp-
ical cells of undetermined significance (ASC-US and ASC-H).
The works de Ruiter et al.18 and Palefsky et al.19 correlated 
the representativeness of the anal transformation zone in 
the conventional sample with diagnostic performance and 
presence of lesions in the anal canal. In the first trial, 154 
conventional cytological samples versus microanoscopy-
guided histological diagnoses of anal biopsy were evaluated, 
and the presence of anal transformation zone cells was con-
sidered as a criterion of adequacy. These authors found a 
sensitivity of 87.5% and a specificity of 16.3%.
Palefsky et al.19 evaluated 658 MSM, and most remained 
in follow-up for two years. These authors correlated the 
conventional cytopathological exam with high-resolution 
anoscopy and histopathology. The results were grouped ac-
cording HIV status and representativeness of the anal trans-
formation zone in the sample. The HIV-positive participants 
had sensitivity of 69% and specificity of 59%; and the sero-
negative participants, sensitivity of 47% and specificity of 
92%. Palefsky et al. concluded that the absence of columnar 
cells did not affect the diagnosis.
The study showed discrepant results when compar-
ing the samples with and without components of the anal 
transformation zone, in disagreement with the opinion of 
some authors, who consider the presence of cells of the 
anal transformation zone as a qualitative data, without im-
pact on the result. However, recent review articles point out 
that there are few publications addressing the minimum 
standard of adequacy of anorectal samples, and how the 
cellularity influences the sensitivity and specificity of the 
method.1,2
Anal cancer is related to a natural body orifice, and there-
fore its diagnosis should be easy and established early. How-
ever, the fact that is the anus, with all its burden of stigma 
and prejudice, coupled with the fact that its symptoms are 
indistinguishable from symptoms of the most common anal 
Table 5 – Diagnostic performance of cytopathologic exam of smears considered satisfactory, obtained by anal 
cytobrushing, in the detection of macroscopic lesions of anal canal (HFI/MS, 2005-2011).
Macroscopic lesion of  
anal canal present
Macroscopic lesion of  
anal canal absent
Total Sa Eb RP+c
In satisfactory cytological samples
Altered cytology 68 77 145 64% 69% 2.06
Normal cytology 38 179 217
Totals 106 256 362
In satisfactory cytological samples with elements of ZTAd
Altered cytology 57 61 118 80% 60% 2.0
Normal cytology 14 98 112
Totals 71 159 230
In satisfactory cytological samples without elements of ZTAd
Altered cytology 11 16 27 31% 16% 0.37
Normal cytology 24 81 105
Totals 35 97
aSensibility; bspecificity; codds ratio positive; danal transformation zone.
diseases, contributes for diagnoses often obtained at more 
advanced clinical stages and not always of easy solution.20
The recognition of the risk of developing anal cancer is still 
undervalued by physicians and even by those social groups 
whose patients of the so-called risk group have  visibility.2
Conclusion
For the authors, this study demonstrated that the use of the 
conventional cytology method, widely available in our coun-
try, is a viable technology, provided that all the steps of col-
lecting and fixing the samples be performed carefully, includ-
ing allowing their transport when the samples are taken at 
distant locations from the laboratory.
Conflicts of interest
The authors declare no conflicts of interest.
Acknowledgements
I would like to acknowledge the cooperation of all adminis-
trative and technical employees of the Service of Pathology, 
Hospital Federal de Ipanema, Marcos Costa, Marcos Duque 
and my daughter Cristina for her invaluable help.
R E F E R E N C E S
1. Bean SM, Chhieng DC. Anal-rectal cytology: a review. Diagn 
Cytopathol 2010; 38: 538–46. 
2. Darragh TM, Winkler B. Anal cancer and cervical cancer 
screening: key differences. Cancer 2011; 119: 5–19.
3. MINISTÉRIO DA SAÚDE. Instituto Nacional de Câncer José 
Alencar Gomes da Silva (INCA). 2ª edição revista e atualizada. 
Rio de Janeiro, RJ. 2012 .
4. Monitoramento e Avaliação em DST/AIDS. 1/26. Programa 
Municipal de Boletim Epidemiológico 4º Trimestre de 2008. 
Sítio de Excelência em DST/ Aids.
5. Leiman G. Anal screening cytology  CytoJournal 2005; 1-3. 
J  C O L O P R O C T O L .  2 0 1 4 ; 3 4 ( 1 ) : 2 9 – 3 434
6. Nadal SR, Horta SH, Calore EE, Nadal LR, Manzione CR. [Quanto 
a escova deve ser introduzida no canal anal para avaliação 
citológica mais eficaz?] Rev Assoc Med Bras 2009; 55: 749–51.
7. Darragh TM, Jay N, Tupkelewicz BA, Hogeboom CJ, Holly EA, 
Palefsky JM. Comparison of conventional cytologic smears and 
Thin Prep preparations from the anal canal. Acta Cytol 1997; 41: 
1167–70.
8. Darragh TM, Birdsong GG, Luff RD, Davey DD: Anal-rectal 
cytology. In: Solomon D, Nayar R, eds. The Bethesda System 
for Reporting Cervical Cytology: Definitions, Criteria and 
Explanatory Notes. 2nd ed. New York: Springer; 2004:169-
175.Solomon D, Nayar R, editors. The Bethesda System for 
reporting cervical cytology. New York: Springer; 2004.
9. Pesquisa de Conhecimentos, Atitudes e Práticas Relacionadas 
às DST e Aids da População Brasileira de 15 a 64 anos de idade 
– MS, 2008.
10. Jacyntho C, Giraldo P. A importância do exame cito-anuscópico 
sob visão ampliada para o diagnóstico das neoplasias intra-
epiteliais anais em pacientes com neoplasias intra-epiteliais 
genitais. Revista Brasileira de Ginecologia e Obstetrícia 2005; 
27, 44-45. 
11. Nadal SR, Calore EE, Nadal LR, Horta SH, Manzione CR. 
Citologia anal para rastreamento de lesões pré- neoplásicas . 
Rev Assoc Med Bras 2007; 53: 147–51.
12. Park IU, Palefsky JM. Evaluation and management of anal 
intraepithelial neoplasia in HIV-negative and HIV-positive men 
who have sex with men. Curr Infect Dis Rep. 2010;12:126-133.
13. Mathews WC, Sitapati A, Caperna JC, Baber RE, Tugend 
A, Go U. Measurement characteristics of aAnal cytology, 
histopathology, and high-resolution anoscopic visual 
impression in an anal dysplasia screening program. J Acquir 
Immune Defic Synd 2004;37:1610-15.
14. Sherman ME, Friedman HB, Busseniers AE, Kelly WF, Carner 
TC, Saah AJ. Cytologic diagnosis of anal intraepithelial 
neoplasia using smears and cytyc thin-preps. Mod Pathol 
1995; 8: 270–4.
15. Friedlander MA, Stier E, Lin O. Anorectal cytology as a 
screening tool for anal squamous lesions: cytologic, 
anoscopic, and histologic correlation. Cancer 2004; 102: 19–26. 
16. Arain S, Walts AE, Thomas P, Bose S. The anal Pap smear: 
cytomorphology of squamous intraepithelial lesions. 
Cytojournal 2005; 2: 4.
17. Darragh TM, Winkler B. The ABCs of anal-rectal cytology. CAP 
TODAY. May 2004:42–50.
18. de Ruiter A, Carter P, Katz DR, Kocjan G, Whatrup C, 
Northover J, et al. A comparison between cytology and 
histology to detect anal intraepithelial neoplasia. Genitourin 
Med. 1994 Feb;70(1):22–25.
19. Palefsky JM, Holly EA, Hogeboom CJ, et al. Anal cytology as 
a screening tool for anal squamous intraepithelial lesions. J 
Acquir Immune Defic  Syndr Hum Retrovirol. 1997; 14: 415-22.
20. Coutinho, JRH. Rastreamento de lesões pré-neoplásicas do 
ânus — citologia anal e anuscopia de alta resolução. Novas 
armas para prevenção. Rev Col Bras Cir 2006: 33:311-17.
